ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Clinical Trial Manager (Contract to Perm) at Triveni Bio - ApplyBlast

Clinical Trial Manager (Contract to Perm)

Triveni Bio

6 days ago

Watertown, Massachusetts, United States

Onsite

Contract

Manager

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

The Clinical Trial Manager will oversee clinical trials from start-up to close-out, ensuring compliance with GCP, regulatory guidelines, and company policies. This role involves managing day-to-day trial operations, collaborating with cross-functional teams, and ensuring trials are delivered on time, within budget, and to high quality standards. The position requires experience managing phase 1/2 trials and clinical vendor management in a fast-paced biotech environment.

Responsibilities

Manage clinical trial operations from start-up to close-out ensuring GCP and regulatory compliance
Oversee site feasibility, selection, and relationship management while providing investigator training
Monitor trial progress and data quality while managing external vendors and CRO deliverables

Skills

About Triveni Bio

triveni.bio

Headquarters

Watertown, Massachusetts, United States

Company Size

1-10 employees

View Profile

Triveni Bio is a clinical-stage biotechnology company taking a genetics-informed approach and leveraging advanced antibody engineering to develop first-in-class therapeutics for immune and inflammatory (I&I) diseases. The company's pipeline includes bispecific antibodies such as TRIV-573 and TRIV-509, targeting conditions like atopic dermatitis. Triveni's approach is rooted in human genetics and novel biology, aiming to redefine treatment paradigms for patients with uncontrolled inflammatory disease.

Recent company news

PR Newswire

Triveni Doses First Subject in Global Phase 2 Proof of Concept Study of TRIV-509 in Atopic Dermatitis, Presents Translational Data at 2025 EADV Congress Demonstrating Novel Biology in Patient Samples

Sep 23, 2025

Yahoo Finance

Triveni Bio Doses First Healthy Volunteers in Clinical Trial for TRIV-509, Coinciding with Preclinical Data Presentations Further Validating Novel Kallikrein 5/7 Biology in Atopic Dermatitis

May 21, 2025